Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Food, Beverages & Tobacco | Small Cap
Health Score : 5.37Indo US Bio-Tech Ltd, operating in the FMCG sector, demonstrates a mixed financial performance. The company showcases strong profitability with healthy margins and returns on capital and equity. However, its liquidity position is weak, indicating potential challenges in meeting short-term obligations. The company's growth rates are also concerning, showing negative trends in revenue, operating profit, and earnings per share. While the company maintains a reasonable solvency position, its efficiency in utilizing assets is low. The ability to cover interest and dividends is also limited. The financial ratios reflect low earnings per share and book value, but capital expenditures are well-managed. Overall, the company needs to address its liquidity and growth challenges while leveraging its profitability strengths for sustainable financial health.
Health Score : 5.37Indo US Bio-Tech Ltd, operating in the FMCG sector, demonstrates a mixed financial performance. The company showcases strong profitability with healthy margins and returns on capital and equity. However, its liquidity position is weak, indicating potential challenges in meeting short-term obligations. The company's growth rates are also concerning, showing negative trends in revenue, operating profit, and earnings per share. While the company maintains a reasonable solvency position, its efficiency in utilizing assets is low. The ability to cover interest and dividends is also limited. The financial ratios reflect low earnings per share and book value, but capital expenditures are well-managed. Overall, the company needs to address its liquidity and growth challenges while leveraging its profitability strengths for sustainable financial health.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
12.07
Industry Median
16.68
Small Cap Median
16.68
P/E RATIO
28.55
P/B RATIO
3.77
Industry Median
2.01
Small Cap Median
2.01
P/S RATIO
3.44
Industry Median
1.30
Small Cap Median
1.30
Others
PEG RATIO
0.69
EV/EBITDA RATIO
24.92
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹79.09 as on Sep 1, 2026.
Growth Score : 2.00The growth rates show significant negative trends across revenue, operating profit, earnings per share, assets, and net income. This indicates potential challenges in the company's ability to expand and sustain its operations. Addressing these issues is crucial for revitalizing growth and ensuring long-term success.
Revenue Growth RatePoorOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RatePoorNet Income Growth RatePoor| Growth Ratios | Mar 2021 | Mar 2022 |
|---|---|---|
| Revenue Growth Rate | -0.93 | 25.39 |
| Operating Profit Growth Rate | 34.42 | 26.92 |
| Earnings Per Share (EPS) Growth | 94.25 | -18.05 |
| Asset Growth Rate | 25.97 | 27.25 |
| Net Income Growth Rate | 93.68 | 3.27 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jeyyam Global Foods Ltd | 8.14 | 7.84 | Neutral | 30.00 | 2.89 | 14.00 |
| 2 | Sheetal Universal Ltd | 7.88 | 33.73 | Neutral | 21.00 | 10.05 | 12.00 |
| 3 | Upsurge Seeds of Agriculture Ltd | 7.34 | 14.01 | Neutral | 14.00 | 7.42 | 7.00 |
| 4 | Shreeoswal Seeds & Chemicals Ltd | 6.94 | 33.38 | Overvalued | 15.00 | 0.32 | 7.00 |
| 5 | Indo US Bio-Tech Ltd | 5.37 | 28.55 | Highly Overvalued | 6.79 | 6.55 | 5.06 |
| 6 | Nath Bio-Genes (India) Ltd | 4.76 | 6.95 | Neutral | 52.00 | 23.38 | 42.00 |
| 7 | TBI Corn Ltd | 4.72 | 6.75 | Neutral | 35.00 | 10.11 | 19.00 |
| 8 | KCK Industries Ltd | 4.67 | 211.43 | Neutral | 0.02 | 0.07 | 0.42 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Quarterly Report⬤21st Jan 26
Quarterly Financial Results Q3 FY 2025–26
BEARISH SENTIMENT
No Stock News Available at This Moment.
Indo US Bio-Tech Ltd is an Indian agro-chemical company specializing in the manufacturing and marketing of agricultural inputs. The company's core activities include producing bio-fertilizers, bio-pesticides, plant growth regulators, and organic products, addressing crop nutrition and protection needs for various agricultural applications across India.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Indo US Bio-Tech Ltd's P/E ratio (TTM) is 12.07, compared to the industry median of 16.68 and large cap median of 16.68.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Indo US Bio-Tech Ltd's P/B ratio is 3.77, compared to the industry median of 2.01 and large cap median of 2.01.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Indo US Bio-Tech Ltd's P/S ratio is 3.44, compared to the industry median of 1.30 and large cap median of 1.30.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Indo US Bio-Tech Ltd's PEG ratio is 0.69.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Indo US Bio-Tech Ltd's EV/EBITDA ratio is 24.92.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Indo US Bio-Tech Ltd's ROE is 13.14%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Indo US Bio-Tech Ltd's ROA is 12.21%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Indo US Bio-Tech Ltd's ROCE is 15.45%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Indo US Bio-Tech Ltd's operating margin is 13.75%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Indo US Bio-Tech Ltd's net margin is 10.24%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Indo US Bio-Tech Ltd's current ratio is 3.57.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Indo US Bio-Tech Ltd's debt-to-equity ratio is 0.10.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Indo US Bio-Tech Ltd's interest coverage ratio is 5.42.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Indo US Bio-Tech Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Indo US Bio-Tech Ltd's EPS is -18.05.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹79.09. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2004
Headquarters: Mehsana, Gujarat
Core Offerings: Bio-fertilizers, Bio-pesticides, Plant Growth Regulators, Organic Products, Micronutrients
Stock Listing: NSE (INDOUS), BSE (541304)
Promoter: Paragbhai Patel and Family
Indo US Bio-Tech Ltd was incorporated in 2004, initially focusing on developing and manufacturing agricultural inputs. The company expanded its product portfolio to include bio-fertilizers, bio-pesticides, and plant growth regulators. It was listed on the NSE Emerge platform in 2017 and subsequently migrated to the Main Board of NSE in 2021, marking significant milestones in its growth and public presence. The company continues its focus on product innovation and market penetration in the agro-chemical sector.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Agricultural Inputs | 100% | N/A (company-wide EBITDA applies) |
Agricultural Inputs: Focuses on the manufacturing and marketing of a diverse portfolio of bio-fertilizers, bio-pesticides, plant growth regulators, and organic products for crop nutrition and protection.
The company operates its manufacturing facilities in Mehsana, Gujarat, serving agricultural markets across India with a strong emphasis on organic and eco-friendly solutions.
Mr. Paragbhai Patel - Chairman & Managing Director. He is the founder of the company with extensive experience and deep knowledge in the agro-chemical industry, leading its strategic vision and growth initiatives.
No major subsidiaries reported.
Issued bonus shares in 1:1 ratio in November 2023.
The Indo US Bio-Tech Ltd share price today is ₹79.09 on NSE (INDOUS), as of 23 Oct 2026.
As of 23 Oct 2026, Indo US Bio-Tech Ltd share price is ₹79.09, with previous close ₹79.09. Today's range is ₹79.09 to ₹79.09. The 52-week range is ₹65 to ₹154.39.
As of today, Indo US Bio-Tech Ltd's market cap is ₹170.04 crore (Small Cap).
Indo US Bio-Tech Ltd's current P/E ratio is 12.07, compared to the FOOD BEVERAGES & TOBACCO sector average of 58.
Indo US Bio-Tech Ltd's current P/B ratio is 3.77.
Indo US Bio-Tech Ltd's current dividend yield is N/A. Last dividend of ₹0.50 per share was declared on 19-Sep-2024.
Indo US Bio-Tech Ltd's EPS (TTM) is ₹-18.05.
Indo US Bio-Tech Ltd is an Indian agro-chemical company specializing in the manufacturing and marketing of agricultural inputs. The company's core activities include producing bio-fertilizers, bio-pesticides, plant growth regulators, and organic products, addressing crop nutrition and protection needs for various agricultural applications across India.
Indo US Bio-Tech Ltd is promoted by Paragbhai Patel and Family, holding 68.29% as of 23 Oct 2026.
Indo US Bio-Tech Ltd is listed on NSE (INDOUS) and BSE (541304). Its next quarterly results are expected on August 2024.
Capital Expenditures (CapEx)